make ppt of 50 slides for lecture on carcinoma vagina for oncology students with special emphysis on radiotherapy
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Searching PubMed
vaginal carcinoma radiotherapy brachytherapy treatment outcomes
Reading File
Searching Images
vaginal carcinoma staging diagram
Searching Images
brachytherapy vaginal cancer intracavitary applicator
Reading File
Searching Images
vaginal cancer squamous cell histology microscopy
Searching Images
external beam radiation therapy pelvis IMRT cervical vaginal cancer
Running Command
Writing File
Running Command
Running Command
The presentation is ready. Download it here:
Carcinoma Vagina Radiotherapy
Presentation · PPTX
What's Inside — 50 Slides
The deck uses a professional navy/teal/gold colour scheme with a consistent layout. Content is sourced from Berek & Novak's Gynecology and GEC-ESTRO guidelines. Here is the full structure:
| # | Slide Group | Key Content |
|---|---|---|
| 1–2 | Title + Outline | Lecture map across 18 topic areas |
| 3–6 | Epidemiology & Anatomy | Incidence, anatomical relationships, lymphatic drainage relevant to RT fields |
| 7–8 | Risk Factors & DES | HPV, DES/clear-cell adenocarcinoma with histology image |
| 9–11 | Pathology | SCC (80–90%), adenocarcinoma, melanoma, sarcoma, metastatic disease |
| 12–17 | Staging & Spread | Full FIGO table, staging notes, MRI images of Stage I & II, lymphatic patterns, prognostic factors |
| 18–19 | Treatment Overview | Strategy-by-stage table |
| 20–22 | RT Rationale & Principles | Why RT is mainstay; combined EBRT + BT doses; cisplatin concurrent |
| 23–26 | EBRT Technique | 3D-CRT vs IMRT/VMAT; target volumes; nodal fields; IMRT comparison image; dose distribution comparison image |
| 27–35 | Brachytherapy (deep-dive) | IC vs interstitial vs hybrid; Fletcher-Suit applicator; 2D planning radiograph; 3D CT planning; interstitial template; IGABT GEC-ESTRO principles; HDR protocol; tandem-ovoid photo |
| 36–38 | OAR, Toxicity & Palliative RT | Acute & late toxicities; fistula risk; palliative regimens |
| 39–40 | Chemotherapy | Concurrent cisplatin; carboplatin; bevacizumab; pembrolizumab for recurrence |
| 41–43 | Surgery | Two-column: primary surgery vs exenteration for recurrence |
| 44–45 | Survival & Outcomes | 5-yr OS/LC by stage; selected series table with Frank, Dalrymple, GEC-ESTRO data |
| 46–48 | Special Situations + Follow-up + Sequelae | Melanoma, sarcoma; surveillance schedule; acute vs late toxicity management |
| 49–50 | Key Points + Thank You | 12-bullet summary; references |
Embedded clinical images (from medical literature): MRI Stage I & II vaginal SCC, Fletcher-Suit applicator, 2D radiograph BT planning, 3D CT-guided BT planning, interstitial template BT, IMRT vs conventional field comparison, dose distribution comparison (BT vs IMRT/VMAT/Tomo), HDR tandem-ovoid photo, vaginal clear-cell carcinoma histology.
This is a shared conversation. Sign in to Orris to start your own chat.